Pharmaceutical R&D

Pharmaceutical R&D

4.11 - 1251 ratings - Source

12 Because the marginal credit varies with the rate at which a firm is increasing its Raamp;D over time, Altshuler (unlike Baily and ... 1)1 percent of the average annual total qualified research expenses (as calculated for the Raamp;D tax credit) during a 3-year base period; 2) all ... data for the 1981-84 period but did not correct for carryforwards and carrybacks also found instances in which the incentive created byanbsp;...

Title:Pharmaceutical R&D
Publisher:National Academies - 1993


You Must CONTINUE and create a free account to access unlimited downloads & streaming